Capmatinib Plus Nazartinib for EGFR-Mutated NSCLC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
European Journal of Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Capmatinib plus nazartinib in patients with EGFR-mutated non-small cell lung cancer
Eur. J. Cancer 2024 Jun 22;208(xx)114182, E Felip, G Metro, RA Soo, J Wolf, BJ Solomon, DS Tan, A Ardizzoni, DH Lee, LV Sequist, F Barlesi, S Ponce-Aix, DR Abreu, MRG Campelo, M Sprauten, LO Djentuh, N Smith, A Jary, R Belli, S Glaser, M Zou, X Cui, M Giovannini, JC YangFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.